COOThe Cooper Companies
Price
-11%1YEnd-of-day closes, not the intraday tick.
The Cooper Companies, Inc. (Cooper, we or the Company), is a leading global medical device company focused on helping people experience life's beautiful moments. Headquartered in San Ramon, California, Cooper sells products in over 130 countries and positively impacts over fifty million lives each year. Cooper operates through two business segments, CooperVision and CooperSurgical. Our two business segments elevate standards of care with products and services in the fields of vision, fertility and women’s health.
In the company’s own words · 10-K filed Dec 5, 2025 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Business segments
Q2 2026 · $1.08BThe company’s own SEC segment disclosure.
- Toric And Multifocal$364.9M34%
- Sphere Other$358.6M33%
- Office And Surgical$214.2M20%
- Fertility$143.8M13%
The Cooper Companies (COO) reported revenue of $1.07B in Q3 2026 (quarter ended Jul 31, 2026), up 0.6% from the same quarter a year earlier. That came with a gross margin of 67% and net income of $433M (41% of revenue). For the full year FY2025, revenue was $4.09B (+5.1% year on year) and net income $375M. Its largest product in Q2 2026 (quarter ended Apr 30, 2026) was Toric And Multifocal at $365M, 34% of the disclosed total, just ahead of Sphere Other at 33%. The next results filing is expected around Dec 3, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 27, 2026Departure of President and Chief Executive Officer On October 27, 2026, Albert G. White III resigned from the Board of Directors (the “Board”) of The Cooper Companies, Inc. (the “Company”) and he ceased serving in the offices of President and Chief Executive Officer of the Company.Director or officer change · Form 8-K
- Sep 9, 2026On September 9, 2026, the Company issued a press release announcing the completion of its strategic review and an increase in its share repurchase authorization.Earnings release · Form 8-K
- Jun 4, 2026As described in its June 4, 2026 press release, the Company recorded a charge as further described below. In December 2023, CooperSurgical, one of the Company’s two business units, initiated a voluntary recall of three specific lots of CooperSurgical’s LifeGlobal TM global ® embryo culture media that it had produced.Earnings release · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Medical Instruments & Supplies
The closest names by size in the same industry